Andrew R. Robbins

CIK: 0001590157

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COGT

Cogent Biosciences, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

COGT
Cogent Biosciences, Inc.
May 19, 2026
Gift(G)
Direct
160K shares-
COGT
Cogent Biosciences, Inc.
May 19, 2026
Gift(G)
Indirect
160K shares-
COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Award(A)
Direct
185K shares-
COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Award(A)
Direct
840K shares-
COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Tax Payment(F)
Direct
367.5K shares at avg. $39.45$14.5M
COGT
Cogent Biosciences, Inc.
Jan 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
915K shares-

		Type	Shares	Price		Ownership
May 19, 2026	COGT Cogent Biosciences, Inc.	Gift(G)	160,000	-	$0	Direct
May 19, 2026	COGT Cogent Biosciences, Inc.	Gift(G)	160,000	-	$0	Indirect
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Award(A)	185,000	-	-	Direct
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Award(A)	840,000	-	-	Direct
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Tax Payment(F)	367,497	$39.45	$14,497,757	Direct
Jan 23, 2025	COGT Cogent Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	915,000	-	-	Direct

1-6 of 6 transactions

About Robbins Andrew R

Robbins Andrew R (SEC CIK 0001590157) files insider reports with the SEC as President and CEO of Cogent Biosciences, Inc. (COGT).

Signal8 holds 3 ownership filings by Robbins Andrew R, all Form 4s, filed between Jan 27, 2025 and May 21, 2026. Those filings report 6 transactions, from Jan 23, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Robbins Andrew R's filings is in WALTHAM, MA.

Recent filings by Robbins Andrew R

May 19, 2026: Gifts of COGT shares (2 lines, Form 4, code G).
Dec 17, 2025: Grants or awards of COGT shares (2 lines, Form 4, code A).
Dec 17, 2025: Tax withholding of COGT shares (Form 4, code F).
Jan 23, 2025: Grant or award of COGT derivative securities (Form 4, code A).

Other insiders filing for Cogent Biosciences, Inc. (COGT)

Ferrante Karen Jean, Director
Harwin Peter Evan, Director
CAIN CHRISTOPHER W., Director
Shegog Todd, Director
Morris Arlene, Director
Ros Matthew, Director

How to read Form 4 transaction codes